TRCT
BDSX icon

Tower Research Capital (TRC)’s Biodesix BDSX Stock Holding History

Tower Research Capital (TRC)’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14 Sell
1
-192
-99% -$2.38K ﹤0.01% 5067
2025
Q4 		$1.31K Sell
193
-451
-70% -$3.32K ﹤0.01% 4717
2025
Q3 		$4.86K Sell
644
-789
-55% -$6.07K ﹤0.01% 4288
2025
Q2 		$8.09K Buy
1,433
+1,238
+635% +$9.99K ﹤0.01% 4025
2025
Q1 		$2.44K Buy
+195
New +$3.74K ﹤0.01% 4550
2024
Q4 		– Sell
-148
Closed -$5.25K – 5695
2024
Q3 		$5.25K Buy
+148
New +$5.09K ﹤0.01% 4303
2024
Q2 		– Sell
-386
Closed -$11.1K – 5685
2024
Q1 		$11.1K Sell
386
-56
-13% -$1.92K ﹤0.01% 3609
2023
Q4 		$16.3K Sell
442
-1,138
-72% -$35.7K ﹤0.01% 3790
2023
Q3 		$52.1K Buy
+1,580
New +$43.9K ﹤0.01% 2521
2023
Q2 		– Sell
-2
Closed – – 6038
2023
Q1 		$0 Hold
2
– – ﹤0.01% 5811
2022
Q4 		$0 Hold
2
– – ﹤0.01% 5891
2022
Q3 		$0 Sell
2
-106
-98% -$4.09K ﹤0.01% 6059
2022
Q2 		$4K Sell
108
-246
-69% -$8K ﹤0.01% 5170
2022
Q1 		$12K Buy
354
+98
+38% +$6.4K ﹤0.01% 4037
2021
Q4 		$27K Buy
256
+173
+208% +$22.6K ﹤0.01% 3333
2021
Q3 		$14K Buy
83
+33
+66% +$6.26K ﹤0.01% 4022
2021
Q2 		$13K Buy
50
+21
+72% +$6.6K ﹤0.01% 4210
2021
Q1 		$12K Buy
29
+8
+38% +$3.57K ﹤0.01% 4245
2020
Q4 		$8K Buy
+21
New +$6.54K ﹤0.01% 4424

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Tower Research Capital (TRC)'s BDSX Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Biodesix (BDSX) stake by 99% in Q1 2026, selling an estimated $2.38K and leaving 1 share worth $14. The position accounts for ﹤0.01% of the portfolio, ranked #5067.

Tower Research Capital (TRC) first reported a position in BDSX in Q4 2020 and has held it in 19 quarters since. The position peaked at $52.1K in Q3 2023. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

  • Tower Research Capital (TRC) held 1 share of Biodesix worth $14 as of Q1 2026.
  • Tower Research Capital (TRC) sold 192 Biodesix shares in Q1 2026, an estimated $2.38K.
  • Biodesix made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #5067 holding.
  • Tower Research Capital (TRC) first reported a position in Biodesix in Q4 2020 and has held it in 19 quarters since.
  • Tower Research Capital (TRC)'s Biodesix position peaked at $52.1K in Q3 2023.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.